Product NDC: | 55390-035 |
Proprietary Name: | Doxapram Hydrochloride |
Non Proprietary Name: | Doxapram Hydrochloride |
Active Ingredient(s): | 20 mg/mL & nbsp; Doxapram Hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-035 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076266 |
Marketing Category: | ANDA |
Start Marketing Date: | 20030210 |
Package NDC: | 55390-035-01 |
Package Description: | 1 VIAL, MULTI-DOSE in 1 BOX, UNIT-DOSE (55390-035-01) > 20 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 55390-035-01 |
Proprietary Name | Doxapram Hydrochloride |
Package Description | 1 VIAL, MULTI-DOSE in 1 BOX, UNIT-DOSE (55390-035-01) > 20 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 55390-035 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Doxapram Hydrochloride |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20030210 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | DOXAPRAM HYDROCHLORIDE |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Increased Medullary Respiratory Drive [PE],Respiratory Stimulant [EPC] |